Black Rose Industries Dividend 2026 — ₹2 Interim Dividend, Yield & Record Date

At its Board meeting on 31 July 2026, Black Rose Industries approved its unaudited results for the quarter ended 30 June 2026 (Q1 FY27) and declared an interim dividend of ₹2 per equity share — described as a 200% dividend on the paid-up capital of ₹1 face value shares. The company fixed 6 August 2026 as the record date for eligibility.

The dividend rode on a strong quarter: standalone revenue from operations rose to ₹89.08 crore (up ~48.8% year-on-year) and standalone net profit jumped to ₹10.41 crore (up ~145% year-on-year). The statutory auditors, M M Nissim & Co LLP, issued an unmodified limited-review report. Separately, the Board approved the winding up of the Japanese subsidiary, B.R. Chemicals Co. Ltd — a capital-allocation signal worth noting.

Note: The record date of 6 August 2026 has already passed. This report is an analytical record of the event; no live eligibility banner applies.

The "200% dividend" illusion. The 200% figure is calculated on the ₹1 face value, not on the market price. In rupee terms the payout is only ₹2 per share. Against the current market price of roughly ₹106, the real dividend yield from this single interim is about 1.89%.

Classification: Consistent but variable payer. Black Rose has paid dividends every year since FY17, but the payout ratio swings widely — from 8–16% in strong-profit years to 77% in FY25. That volatility means the dividend tracks management's cash-and-confidence view rather than a fixed policy. Per-share amounts for individual interim/final tranches across years are NIV and should be reconciled against official exchange filings before republishing.

The step-up to a ₹2 interim at the very start of FY27 — before the year's profits are even booked — is the most aggressive early-year payout in the company's recent history and signals management confidence in FY27 cash flows.

The non-obvious finding — profit grew while revenue shrank. In FY26, sales fell ~17% yet net profit still rose ~7%. That is margin-led profit: operating margin expanded (roughly 8% to 10%) as the mix shifted toward higher-value manufacturing and the low-margin distribution top-line contracted. In Q1 FY27 the leverage worked the other way — revenue up ~49% but profit up ~145%, meaning profit grew roughly 3x faster than sales (positive operating leverage). Return ratios remain healthy: ROCE ~18.9% and ROE ~14%.

Reported profits are opinions; cash is fact — and here the cash story is the headline. In FY25 the company reported a healthy ₹21 crore profit, but its operating cash flow was actually NEGATIVE at about –₹13 crore, and free cash flow was about –₹16 crore. In plain terms: the FY25 dividends were not funded by that year's operations — they leaned on the balance sheet while working capital ballooned.

FY26 reversed this sharply. Operating cash flow swung to +₹45 crore and free cash flow to +₹38 crore, as stretched inventory and receivables unwound. On these FY26 numbers, the ₹10.2 crore FY27 interim outflow is covered 4.4x by operating cash flow and 3.7x by free cash flow — comfortable.

Overall verdict: Sustainable, with one nuance. On full-year earnings, FY26 cash flow, and a debt-free balance sheet, the ₹2 interim is comfortably affordable. The single caution: the ₹2 interim almost equals the entire ₹2.04 Q1 EPS (a ~98% single-quarter payout), so continued heavy payouts depend on the strong Q1 momentum holding through FY27. If the FY25-style negative cash-flow pattern were to recur, the margin of safety would narrow quickly.

Since April 2020, dividends in India are taxed in the hands of the investor at their applicable income-tax slab rate (dividend distribution tax was abolished). The company deducts TDS at 10% only if total dividend paid to a resident shareholder exceeds ₹5,000 in a financial year (10% applies where PAN is available; 20% without PAN).

Worked Example — 1,000 shares, ₹2/share, 30% slab

Positives: Effectively debt-free; a ₹10.2 crore payout covered 3–4x by FY26 cash flows; strong Q1 FY27 momentum (revenue +49%, profit +145%); healthy ~19% ROCE; and a real yield (~1.9%) above its industry norm.

Negatives / cautions: The "200%" headline overstates the ₹2 real payout; FY25 showed that reported profit did not translate to cash; sales have been shrinking; and the ₹2 interim consumes almost the whole Q1 EPS, so future payouts hinge on momentum continuing.

In short, this is a cash-backed interim from a debt-free small-cap whose profit engine has shifted from top-line growth to margin and mix. The information above is presented so readers can weigh it themselves — this article offers no buy, sell, or hold recommendation.